FindTrial
Sign In

Comparison of ketofol and propofol as induction agent on i-gel insertion conditions in paediatric patients.

Comparison of ketofol and propofol as induction agent on ease of i-gel supraglottic airway insertion in paediatric patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/036073
Enrollment
90
Registered
2021-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: I-gel supraglottic airway insertion with different inducing agent drugs.: I Intervention2: i-gel supraglottic airway insertion with different inducing agent drugs.: i-gel supraglottic

Sponsors

Pt B D Sharma PGIMS Rohtak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical classification I & II paediatric patients undergoing short elective surgeries up to 2 hours duration under general anaesthesia using I-gel supraglottic airway.

Exclusion criteria

Exclusion criteria: Paediatric patients with reactive airway, anticipated difficult airway, risk of aspiration, overweight ( Body-mass index at or above 95th percentile), underweight (Body-mass index at or below 5th percentile), history of seizure disorder, psychiatric disorder, increased intracranial or intraocular pressure, contraindications for propofol and ketamine will be excluded from study.

Design outcomes

Primary

MeasureTime frame
To compare i-gel supraglottic airway insertion conditions with two different ratios of ketamine-propofol admixture (ketofol) 1:2, 1:4 and propofol as induction agent.Timepoint: BIS (Bispectral index) value of less than or equal to 40—

Secondary

MeasureTime frame
Haemodynamic stability including heart rate, systolic blood pressure, diastolic blood pressure, mean blood pressure, SpO2.Timepoint: 1. Basal 2. Immediately following induction of anaesthesia. 3. Immediately after i-gel supraglottic airway insertion. 4. 3 minutes after i-gel supraglottic airway insertion. 5. 5 minutes after i-gel supraglottic airway insertion. 6. 10 min after i-gel supraglottic airway insertion.;Local pain at injection siteTimepoint: At the time of study drug injection.—

Countries

India

Contacts

Public ContactJoseph Deeven Kranthikar Chiluka

Pt. B. D. Sharma PGIMS, Rohtak

dr.jatinlal@gmail.com9728265511

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026